The Link Between Ambulatory Dysfunction and Mortality in Cancer Survivors
Lower ambulatory function was observed across 9 cancer types, with the strongest associations observed in patients with respiratory and oral cancers.
Lower ambulatory function was observed across 9 cancer types, with the strongest associations observed in patients with respiratory and oral cancers.
Since the US Supreme Court overturned Roe v Wade last year, restrictions on access to abortion have had a negative impact on cancer care.
Sexual dysfunction may be common in cancer patients and survivors, but their sexual health is often overlooked.
This report reviews the challenges patients with bladder cancer experience related to cystectomy and urinary diversion surgery.
Timely discussions about end-of-life preferences can ensure patients with advanced cancer receive care that aligns with their goals, experts say.
Aggregated data can hide disparities in cancer incidence and outcomes among Asian and Native Hawaiian/Pacific Islander patients in the US.
AML research presented at ASH 2022 highlighted promising combination regimens and suggested that some patients may benefit from less intensive treatment.
Experts discuss the challenges and potential resolutions for increasing diversity of clinical trial study populations.
Long-term cumulative exposure to air pollution should be included in assessments of lung cancer risk, according to researchers.
Recent exposure to systemic treatment does not increase the risk of 30-day mortality in patients with thoracic cancers and COVID-19.